Avoid common mistakes on your manuscript.
4.15 Elevated B-Type Natriuretic Peptide Indicates Increased End-Diastolic Pressure in Patients with Mild-Moderate Heart Failure and Systolic Dysfunction: The AREA-IN-CHF Study
Introduction: Although B-type natriuretic peptide (BNP) is a marker of severity of LV dysfunction, it is only modestly related to echocardiographic indices of LV filling. Little is known on its relation with left atrial volume (LAV), and echocardiographically-estimated LV end-diastolic pressure (LVEDP).
Methods: The AREA-IN-CHF (AntiRemodeling Effect of Aldosterone receptors blockade with canrenone IN mild Chronic Heart Failure) is a prospective, randomized, double blind study on antialdosterone treatment in patients with Class 2 NYHA chronic heart failure (CHF) and ejection fraction <45%. Among 505 participants who underwent Doppler-echocardiography, we evaluated 277 subjects without valvular of rhythm abnormalities (mean age 62.4±9.7 yrs, 45 women), with available BNP. LAV was calculated using biplanes orthogonal dimensions by the ellipsoidal model. As recommended, BNP was considered increased when > 100pg/mL. LVEDP was computed from pulmonary and mitral A wave duration, applying an invasively-validated equation.
Results: BNP correlated positively to age (r=0.25), LV mass (r=0.21), LAV (r=0.36), LVEDP (r=0.41) and negatively to ejection fraction (r=−0.36) and mitral E deceleration time (r=−0.22) (p for all LVEDP, lower ejection fraction and relative wall thickness, and shorter mitral E deceleration time. In binary logistic regression, presence of increased BNP was predicted by LAV (OR= 1.02/ml; 95%CI=1.01−1.05; pLVEDP (OR= 1.07/mmHg; 95%CI=1.02−1.13; p<0,05).
Conclusions: In a cohort of 277 patients in NYHA class 2 CHF without valvular of rhythm abnormalities, increased BNP is frequent (40.4%) and associated with dilated LA and elevated LVEDP, independently of LV geometry and function.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chinali, M., de Simone, G., Mureddu, G.F. et al. 4.15 Elevated B-Type Natriuretic Peptide Indicates Increased End-Diastolic Pressure in Patients with Mild-Moderate Heart Failure and Systolic Dysfunction: The AREA-IN-CHF Study. High Blood Press Cardiovasc Prev 14, 145 (2007). https://doi.org/10.2165/00151642-200714030-00069
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151642-200714030-00069